RASCASE 1.5MG

RASCASE 1.5MG INJ is an injectable medication primarily used in the management of high levels of uric acid in the blood, which can occur in certain medical conditions, such as cancer treatment. By helping to lower uric acid levels, it supports patients who may be at risk of developing complications related to excessive uric acid, allowing them to better manage their overall health during and after treatment.

The active ingredient, Rasburicase, works by breaking down uric acid in the body, transforming it into a more easily excretable form. This helps to reduce the buildup of uric acid crystals, which can lead to discomfort and other health issues. Its action is particularly beneficial for individuals undergoing treatments that may increase uric acid levels, providing a supportive role in their management.

For best results, it’s important to store RASCASE 1.5MG INJ as directed, usually in a cool, dry place, and to ensure that it remains at the recommended temperature. Patients should also be aware of general precautions, such as discussing their complete medical history with their healthcare provider before use.

Common side effects may include mild reactions at the injection site, headache, or nausea. Most people tolerate the treatment well, but it’s important to be vigilant about any new or unusual symptoms.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.